Banner

Per recent study, patients with B-cell NHL (non-Hodgkins Lymphoma) who failed to respond to prior treatment therapies show positive results when given mosunetuzumab, a new investigational drug. This new drug targets two proteins, one on the surface of tumor cells and the other on the surface of the recipient’s T cells. The study has been...

Black men are nearly 2.5 times more likely to be diagnosed with and die of prostate cancer compared to non-Hispanic white men.  A new study aims to debunk the long-held belief that this is due to genetic factors. JAMA Oncology’s research team led by the U-M Rogel Cancer Center analyzed data from more than 300,000...

December 2019 Clinical Trials Update With Dr. Keith Crawford from the Prostate Health Education Network Visit http://www.prostatehealthed.org/phen_tv_video.php?tv_id=291 for monthly updates on clinical trials

According to the National Institute of Health (NIH), fewer than 10% of patients enrolled in clinical trials are minorities. This begs the question whether clinical trials data and research are truly relevant. Dr. Consuelo Hopkins Wilkins is a researcher at Washington University School of Medicine in St. Louis who experiences challenges recruiting older African Americans...

Coronary artery disease is the most common type of heart disease. Atherosclerosis causes the arteries to narrow and harden, cutting off blood supply to the heart.  Not only is coronary artery disease more prevalent in African-Americans, it also starts at an earlier age. Studies have shown that African-Americans also have the highest mortality rates from...

A Baylor University study found that a significantly higher number of African Americans had peripheral artery disease (PAD) compared to Hispanics and whites in patients over the age of 55. Peripheral artery disease is defined as atherosclerosis of the abdominal aorta and the arteries in the legs. PAD can be asymptomatic or symptomatic. Symptoms of...

Most of the latest Multiple Sclerosis treatments cater to relapsing and remitting MS patients. Until Roche’s blockbuster drug Ocrevus launched for progressive MS, patients with progressive and advanced multiple sclerosis had not benefitted as much from therapeutic innovations in the MS space. Renowned neurologist, Robert Fox indicates that he always is very transparent with newly...

Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in the United States. In fact, it is often considered a disease primarily isolated to the Western world. There are remarkable patterns in the incidence of the disease among ethnicities. It most commonly appears in Caucasian individuals and markedly less so in non-Caucasians. For...

Although the overall rate of people dying from cancer in the United States has dropped 27% in the past 25 years, some disadvantaged populations didn’t see the same decline. “We’re making progress against cancer in the United States, but some groups aren’t benefitting as much as others,” said Kassandra Alcaraz, PhD, MPH. “Health is affected...